Bioactivity of mushrooms against cancer

dc.contributor.authorSingh, M. P.
dc.contributor.authorMishra, Vartika
dc.contributor.authorSingh, Narsingh
dc.date.accessioned2023-07-07T15:54:35Z
dc.date.available2023-07-07T15:54:35Z
dc.date.issued2023-06-14
dc.descriptionSPIE Defense + Commercial Sensing, 2023, Orlando, Florida, United Statesen_US
dc.description.abstractOyster mushroom has long been consumed for their delicious taste and flavour that they add to our plate. These edible herbs are also rich source of neutraceuticals that impart on it potential free radical scavenging, antioxidant, antiatherogenic, anti-tumor, immunomodulatory and anti-bacterial properties. In the present study, we deciphered the role of mushroom neutraceuticals vis a vis hallmarks of cancer via an in-silico approach. From literature survey, eleven bioactive compounds of Pleurotus ostreatus were identified e.g. Ergosterol, Rutin, β-glucan, Apigenin, Ascorbic acid, Cinnamic acid, Linoleic acid, Niacinnamide, p-coumaric acid, syringic acid and veratric acid. Molecular docking was performed taking these compounds as ligands against epidermal growth factor receptor, caspase 3 and vascular endothelial growth factor proteins, which plays important role in proliferation, apoptosis and angiogenesis of malignant cells. Our finding suggest that Rutin, Ergosterol and β-glucan has shown highest binding affinity against the three proteins and interfere in their functioning inside tumor microenvironment thereby inhibiting process of carcinogenesis and metastasis.en_US
dc.description.sponsorshipAuthors are thankful to University of Allahabad for encouraging the qualitative research. MPS is thankful to Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India and SERB, Department of Science & Technology, Government of India for sanctioning ITS (International Travel Support) Grant to present paper in the Conference at Orlando, Florida, USA.en_US
dc.description.urihttps://www.spiedigitallibrary.org/conference-proceedings-of-spie/12548/1254807/Bioactivity-of-mushrooms-against-cancer/10.1117/12.2662755.fullen_US
dc.format.extent8 pagesen_US
dc.genreconference papers and proceedingsen_US
dc.genrejournal articlesen_US
dc.identifierdoi:10.13016/m2y5dg-dril
dc.identifier.citationM. P. Singh, Vartika Mishra, N. B. Singh, "Bioactivity of mushrooms against cancer," Proc. SPIE 12548, Smart Biomedical and Physiological Sensor Technology XX, 1254807 (14 June 2023); https://doi.org/10.1117/12.2662755en_US
dc.identifier.urihttps://doi.org/10.1117/12.2662755
dc.identifier.urihttp://hdl.handle.net/11603/28460
dc.language.isoen_USen_US
dc.publisherSPIEen_US
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Chemistry & Biochemistry Department Collection
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Computer Science and Electrical Engineering Department
dc.rights©2023 Society of Photo-Optical Instrumentation Engineers (SPIE). One print or electronic copy may be made for personal use only. Systematic reproduction and distribution, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper are prohibited.en_US
dc.titleBioactivity of mushrooms against canceren_US
dc.typeTexten_US
dcterms.creatorhttps://orcid.org/0000-0002-1810-0283en_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1254807.pdf
Size:
608.93 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description: